Pages that link to "Q36375668"
Jump to navigation
Jump to search
The following pages link to In vivo role of complement-interacting domains of herpes simplex virus type 1 glycoprotein gC (Q36375668):
Displaying 50 items.
- High-level expression of Marek's disease virus glycoprotein C is detrimental to virus growth in vitro (Q24522734) (← links)
- Blocking antibody access to neutralizing domains on glycoproteins involved in entry as a novel mechanism of immune evasion by herpes simplex virus type 1 glycoproteins C and E (Q24646778) (← links)
- IgG in cervicovaginal mucus traps HSV and prevents vaginal herpes infections (Q30585914) (← links)
- Complement Evasion Strategies of Viruses: An Overview (Q33804431) (← links)
- Herpes simplex virus type 1 glycoprotein E domains involved in virus spread and disease (Q33808376) (← links)
- Recent progress in herpes simplex virus immunobiology and vaccine research (Q33963713) (← links)
- Further analysis of Marek's disease virus horizontal transmission confirms that U(L)44 (gC) and U(L)13 protein kinase activity are essential, while U(S)2 is nonessential. (Q33963979) (← links)
- Complement and innate immunity. (Q33974407) (← links)
- Complement evasion by Borrelia burgdorferi: serum-resistant strains promote C3b inactivation. (Q34007675) (← links)
- Blocking herpes simplex virus 2 glycoprotein E immune evasion as an approach to enhance efficacy of a trivalent subunit antigen vaccine for genital herpes (Q34057952) (← links)
- Complement and viral pathogenesis (Q34162421) (← links)
- Herpes simplex virus type 1 evades the effects of antibody and complement in vivo (Q34345831) (← links)
- Herpes simplex virus type 1 and 2 glycoprotein C prevents complement-mediated neutralization induced by natural immunoglobulin M antibody. (Q34545821) (← links)
- An HSV-2 Trivalent Vaccine Is Immunogenic in Rhesus Macaques and Highly Efficacious in Guinea Pigs. (Q34549656) (← links)
- ICP22 is required for wild-type composition and infectivity of herpes simplex virus type 1 virions (Q35101439) (← links)
- Viral mimicry of the complement system (Q35122624) (← links)
- Effects of innate immunity on herpes simplex virus and its ability to kill tumor cells (Q35131235) (← links)
- Complement: structure, functions, evolution, and viral molecular mimicry (Q35176375) (← links)
- Herpes and pox viral complement control proteins: 'the mask of self'. (Q35216397) (← links)
- Activation and evasion of innate antiviral immunity by herpes simplex virus (Q35259878) (← links)
- Complement and dilated cardiomyopathy: a role of sublytic terminal complement complex-induced tumor necrosis factor-alpha synthesis in cardiac myocytes (Q35747641) (← links)
- Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene (Q35760833) (← links)
- Virulence genes in herpes simplex virus type 1 corneal infection (Q35932197) (← links)
- Marek's disease virus expresses multiple UL44 (gC) variants through mRNA splicing that are all required for efficient horizontal transmission (Q36171893) (← links)
- Immune evasion by herpes simplex virus type 1, strategies for virus survival (Q36372405) (← links)
- Sequence diversity of the Trypanosoma cruzi complement regulatory protein family (Q36421495) (← links)
- The immunologic basis for severe neonatal herpes disease and potential strategies for therapeutic intervention (Q36765590) (← links)
- A replication-competent, neuronal spread-defective, live attenuated herpes simplex virus type 1 vaccine (Q36845870) (← links)
- Blocking Immune Evasion as a Novel Approach for Prevention and Treatment of Herpes Simplex Virus Infection (Q37060288) (← links)
- Host responses to wild-type and attenuated herpes simplex virus infection in the absence of Stat1 (Q37099709) (← links)
- An HSV-1 gD mutant virus as an entry-impaired live virus vaccine (Q37188380) (← links)
- Immunization with HSV-1 glycoprotein C prevents immune evasion from complement and enhances the efficacy of an HSV-1 glycoprotein D subunit vaccine (Q37439603) (← links)
- Rapid host immune response and viral dynamics in herpes simplex virus-2 infection (Q37694574) (← links)
- The procoagulant envelope virus surface: contribution to enhanced infection (Q38206635) (← links)
- Improving immunogenicity and efficacy of vaccines for genital herpes containing herpes simplex virus glycoprotein D. (Q38241377) (← links)
- The Neonatal Fc Receptor and Complement Fixation Facilitate Prophylactic Vaccine-Mediated Humoral Protection against Viral Infection in the Ocular Mucosa. (Q38650844) (← links)
- Viral-derived complement inhibitors: current status and potential role in immunomodulation (Q38995165) (← links)
- Interaction of CSFV E2 protein with swine host factors as detected by yeast two-hybrid system (Q39274226) (← links)
- Interindividual Spread of Herpesviruses. (Q39320366) (← links)
- Virus inhibition of RIP3-dependent necrosis (Q39711744) (← links)
- Glycoprotein C of herpes simplex virus type 1 is required to cause keratitis at low infectious doses in intact rabbit corneas. (Q40498724) (← links)
- In vitro characterization of felid herpesvirus 1 (FHV-1) mutants generated by recombineering in a recombinant BAC vector. (Q40682904) (← links)
- Critical role of complement and viral evasion of complement in acute, persistent, and latent gamma-herpesvirus infection (Q40708603) (← links)
- Felid herpesvirus type 1 infection in cats: a natural host model for alphaherpesvirus pathogenesis (Q41482036) (← links)
- Dissecting the regions of virion-associated Kaposi's sarcoma-associated herpesvirus complement control protein required for complement regulation and cell binding. (Q41810495) (← links)
- Functional analysis of HSV-gC1 on swine endothelial cells: potential for xenotransplantation (Q44319297) (← links)
- Copycat viruses outwit the immune system (Q44490050) (← links)
- Strategies developed by bacteria and virus for protection from the human complement system (Q44995164) (← links)
- The Kaposi's sarcoma-associated herpesvirus complement control protein mimics human molecular mechanisms for inhibition of the complement system (Q45013859) (← links)
- Implications for herpes simplex virus vaccine strategies based on antibodies produced to herpes simplex virus type 1 glycoprotein gC immune evasion domains (Q45453302) (← links)